Cipla Notifies Shareholders & Creditors on Inzpera Healthsciences Amalgamation Scheme

Cipla Limited announced that it is sending notices to its shareholders and creditors regarding the Scheme of Amalgamation (by Absorption) of Inzpera Healthsciences Limited with Cipla Limited. This action is in compliance with an order passed by the Hon’ble National Company Law Tribunal (NCLT), Mumbai Bench, on August 18, 2026.

The notices, along with a copy of the Scheme and the NCLT Order, are being disseminated via electronic mode where email addresses are available, and through physical mode for the remaining shareholders and creditors. These notices provide an opportunity for shareholders and creditors to submit any representations concerning the proposed Scheme to the Hon’ble NCLT within 30 days from the date of receipt of the notice.

Inzpera Healthsciences Limited is the Transferor Company, and Cipla Limited is the Transferee Company. The NCLT order dated August 18, 2026, has dispensed with the meetings of equity shareholders and unsecured creditors of Cipla Limited. As there are no secured creditors in Cipla Limited, their meeting is also not required. If no representation is received by the Hon’ble NCLT within the stipulated 30-day period, it will be presumed that the concerned shareholder or creditor has no objection to the proposed Scheme. The notice, NCLT order, and the Scheme of Amalgamation are accessible on Cipla's website.